Simianalytica
GhostSimianalytica covers diabetes device technology, offering regulatory analysis of new glucose monitoring products such as Biolinq's FDA De Novo classification and commentary on noninvasive glucose efforts. Readers get concise explanations of regulatory details, product code assignments and industry developments, though the sampled issues are short and partly link-based.